BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.330
-0.040 (-2.92%)
At close: Jul 28, 2026, 4:00 PM EDT
1.318
-0.012 (-0.89%)
Pre-market: Jul 29, 2026, 4:16 AM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $10.03 million as of July 29, 2026. Its market cap has decreased by -27.84% in one year.
Market Cap
10.03M
Enterprise Value
-2.77M
1-Year Change
-27.84%
Ranking
Category
Stock Price
$1.33
ChartMarket Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $10.03M, a decrease of -80.71%. That is a compound annual growth rate of -24.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 10.00M | 14.94% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 11.31M |
| Kiora Pharmaceuticals | 11.30M |
| Psyence Biomedical | 11.25M |
| Exicure | 11.22M |
| Lunai Bioworks | 10.56M |
| Theriva Biologics | 10.23M |
| Chemomab Therapeutics | 9.79M |
| BioCardia | 9.67M |